http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-201270537-A1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-426 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-51 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-501 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-54 |
| filingDate | 2010-10-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2012-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EA-201270537-A1 |
| titleOfInvention | COMBINATION |
| abstract | The invention relates to a method for treating cancer in a mammal and to pharmaceutical combinations that can be used with such treatment. In particular, this method relates to a new combination comprising an MEK inhibitor N- {3- [3-cyclopropyl-5- (2-fluoro-4-iodo-phenylamino) -6,8-dimethyl-2,4,7 -trioxo-3,4,6,7-tetrahydro-2H-pyrido [4,3-d] pyrimidin-1-yl] phenyl} acetamide or a pharmaceutically acceptable salt or solvate thereof and PI3 kinase inhibitor: 2,4-difluoro -N- {2- (methyloxy) -5- [4- (4-pyridazinyl) -6-quinolinyl] -3-pyridinyl} benzenesulfonamide or a pharmaceutically acceptable salt thereof, to pharmaceutical compositions comprising these compounds and to methods the use of such combinations in the treatment of cancer. |
| priorityDate | 2009-10-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 23.